GlassScriptPhysician profile
Nitin Chhabra
NPI 1811035371
$9,140.34
in general payments reported to CMS, 2019-2025
46 companies · $673 in 2025
The $673 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,682 · 2020: $1,375 · 2021: $1,942 · 2022: $1,627 · 2023: $730 · 2024: $1,111 · 2025: $673.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,513.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,135.44 | 2019-2025 | Superion Indirect Decompression System, Intracept |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,665.90 | 2019-2025 | Relistor, Trulance |
| Collegium Pharmaceutical, INC. | $696.90 | 2019-2025 | Xtampza, Belbuca |
| Abbott Laboratories | $589.51 | 2019-2024 | Proclaim |
| Nevro Corp. | $258.65 | 2019 | |
| Scilex Pharmaceuticals INC. | $246.72 | 2019-2024 | |
| Medtronic, INC. | $227.96 | 2022-2025 | Intellis Adaptivestim, Inceptiv |
| Abbvie INC. | $191.23 | 2021-2022 | |
| Amgen INC. | $182.86 | 2019-2021 | |
| Redhill Biopharma INC. | $165.36 | 2020-2022 | |
| Spinefrontier, INC. | $145.43 | 2024 | Sijfuse |
| Indivior INC. | $141.82 | 2019-2021 | |
| Pacira Therapeutics, INC. | $129.79 | 2019-2021 | |
| Pfizer INC. | $112.42 | 2019-2021 | |
| Forte Bio-Pharma LLC | $98.86 | 2020-2024 | Prolate, Nalocet |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nitin Chhabra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.